Cervical Cancer
The Problem Remains
Current screening methods are not optimal
GLOBAL CERVICAL CANCER
FACTS & FIGURES
- 500,000+ women each year are newly diagnos Cervical Cancer
- 300,000 + women die each year of Cervical Ca
- 90%+ of eligible women (1 billion) don’t have acscreening
The Problem Remains
Current screening methods are not optimal
GLOBAL CERVICAL CANCER
FACTS & FIGURES
- 500,000+ women each year are newly diagnos Cervical Cancer
- 300,000 + women die each year of Cervical Ca
- 90%+ of eligible women (1 billion) don’t have acscreening
Cervical Cancer Screening Methods
Cytology (Pap Smear) alone has low sensitivity & specificity rates – as low
as 11% and 14% respectively —for detecting high-grade cervical disease.
Current HPV self-sampling kits still need additional screening to diagnose treatable
conditions
Cytology + HPV co-testing for high-grade cervical disease hasa 98% negative predictive value
Visual Inspection has a
21% false positive rate
and requires extensive
training & visual acuity of
the clinician
Digital colposcopy, even
with Al, remains.
suboptimal due to high
cost, advanced training,
and variability of results
